Abraham R. Eliakim

2.2k total citations
31 papers, 766 citations indexed

About

Abraham R. Eliakim is a scholar working on Surgery, Gastroenterology and Genetics. According to data from OpenAlex, Abraham R. Eliakim has authored 31 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Gastroenterology and 9 papers in Genetics. Recurrent topics in Abraham R. Eliakim's work include Gastrointestinal Bleeding Diagnosis and Treatment (10 papers), Inflammatory Bowel Disease (9 papers) and Gastrointestinal disorders and treatments (7 papers). Abraham R. Eliakim is often cited by papers focused on Gastrointestinal Bleeding Diagnosis and Treatment (10 papers), Inflammatory Bowel Disease (9 papers) and Gastrointestinal disorders and treatments (7 papers). Abraham R. Eliakim collaborates with scholars based in Israel, United Kingdom and United States. Abraham R. Eliakim's co-authors include Alexander Lossos, Yaron River, Israel Steiner, Dan Nemet, Uri Kopylov, Baruch Wolach, Orit Friedland, Anton LeMair, Khean‐Lee Goh and S S Fedail and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Neurology.

In The Last Decade

Abraham R. Eliakim

28 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abraham R. Eliakim Israel 12 253 234 232 176 83 31 766
Cong Dai China 22 264 1.0× 295 1.3× 222 1.0× 295 1.7× 73 0.9× 78 1.2k
Hüseyin Anıl Korkmaz Türkiye 16 215 0.8× 124 0.5× 92 0.4× 120 0.7× 70 0.8× 85 775
K Wakabayashi Japan 15 413 1.6× 155 0.7× 167 0.7× 142 0.8× 68 0.8× 34 998
Reza Ansari Iran 15 354 1.4× 102 0.4× 430 1.9× 268 1.5× 137 1.7× 45 1.1k
Puneet Gupta United States 14 245 1.0× 158 0.7× 64 0.3× 180 1.0× 49 0.6× 61 1.1k
Bożena Birkenfeld Poland 12 136 0.5× 110 0.5× 235 1.0× 70 0.4× 56 0.7× 56 784
Stefan‐Lucian Popa Romania 15 117 0.5× 46 0.2× 133 0.6× 212 1.2× 35 0.4× 96 669
Carlo Tolone Italy 14 287 1.1× 83 0.4× 420 1.8× 268 1.5× 37 0.4× 45 827
Yoshiharu Yamaguchi Japan 13 195 0.8× 53 0.2× 164 0.7× 75 0.4× 94 1.1× 45 701
Lijun Du China 17 373 1.5× 61 0.3× 441 1.9× 58 0.3× 103 1.2× 38 889

Countries citing papers authored by Abraham R. Eliakim

Since Specialization
Citations

This map shows the geographic impact of Abraham R. Eliakim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham R. Eliakim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham R. Eliakim more than expected).

Fields of papers citing papers by Abraham R. Eliakim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abraham R. Eliakim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham R. Eliakim. The network helps show where Abraham R. Eliakim may publish in the future.

Co-authorship network of co-authors of Abraham R. Eliakim

This figure shows the co-authorship network connecting the top 25 collaborators of Abraham R. Eliakim. A scholar is included among the top collaborators of Abraham R. Eliakim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham R. Eliakim. Abraham R. Eliakim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Levhar, Nina, Rotem Hadar, Orit Picard, et al.. (2024). DOP09 Models for predicting Crohn Disease (CD) exacerbation using serum and fecal metabolomics. Journal of Crohn s and Colitis. 18(Supplement_1). i88–i89. 1 indexed citations
3.
Leenhardt, Romain, Cynthia Li, Anastasios Koulaouzidis, et al.. (2018). Sa1028 TERMINOLOGY AND DESCRIPTION OF VASCULAR LESIONS IN SMALL BOWEL CAPSULE ENDOSCOPY: AN INTERNATIONAL DELPHI CONSENSUS STATEMENT. Gastrointestinal Endoscopy. 87(6). AB149–AB150. 1 indexed citations
5.
Koulaouzidis, Anastasios, Dimitris K. Iakovidis, Diana E. Yung, et al.. (2017). KID Project: an internet-based digital video atlas of capsule endoscopy for research purposes. SHILAP Revista de lepidopterología. 5(6). E477–E483. 82 indexed citations
6.
Bernstein, Çharles N., Abraham R. Eliakim, S S Fedail, et al.. (2016). World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 50(10). 803–818. 154 indexed citations
7.
Kopylov, Uri, Dan Carter, & Abraham R. Eliakim. (2016). Capsule Endoscopy and Deep Enteroscopy in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America. 26(4). 611–627. 4 indexed citations
8.
Ungar, Bella, Miri Yavzori, Ella Fudim, et al.. (2016). Sa1953 Addition of an Immunomodulator Can Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab. Gastroenterology. 150(4). S414–S414.
9.
Rozendorn, Noa, Eyal Klang, Adi Lahat, et al.. (2015). Prediction of patency capsule retention in known Crohn's disease patients by using magnetic resonance imaging. Gastrointestinal Endoscopy. 83(1). 182–187. 54 indexed citations
10.
Yanai, Henit, Lev Lichtenstein, Amit Assa, et al.. (2014). Su1121 Anti-TNF and Anti-Drug Antibodies Levels Predict the Outcomes of Interventions After Loss of Response to Adalimumab and Infliximab. Gastroenterology. 146(5). S–381. 1 indexed citations
11.
Hunt, Richard H., Eamonn M.M. Quigley, Zaigham Abbas, et al.. (2014). Coping With Common Gastrointestinal Symptoms in the Community. Journal of Clinical Gastroenterology. 48(7). 567–578. 28 indexed citations
12.
Eliakim, Abraham R., et al.. (2010). Effect of HMB Supplementation on Body Composition, Fitness, Hormonal Profile and Muscle Damage Indices. Journal of Pediatric Endocrinology and Metabolism. 23(7). 641–50. 29 indexed citations
13.
Nemet, Dan, et al.. (2009). Immunological and Growth Mediator Response to Cross-Country Training in Adolescent Females. Journal of Pediatric Endocrinology and Metabolism. 22(11). 995–1007. 6 indexed citations
14.
Zadik, Zvi, Dan Nemet, & Abraham R. Eliakim. (2009). Hormonal and Metabolic Effects of Nutrition in Athletes. Journal of Pediatric Endocrinology and Metabolism. 22(9). 769–77. 8 indexed citations
15.
Franchis, Roberto de, Glenn M. Eisen, Abraham R. Eliakim, et al.. (2007). Esophageal Capsule Endoscopy (PillCam ESO) Is Comparable to Traditional Endoscopy for Detection of Esophageal Varices-An International Multi-Center Trial. Gastrointestinal Endoscopy. 65(5). AB107–AB107. 6 indexed citations
16.
Eliakim, Abraham R.. (2006). Video capsule endoscopy of the small bowel (PillCam SB). Current Opinion in Gastroenterology. 22(2). 124–127. 33 indexed citations
17.
Constantini, Naama, et al.. (2001). [Vaccinations in sports and recommendations for immunization against flu, hepatitis A and hepatitis B].. PubMed. 140(12). 1191–5, 1228. 7 indexed citations
18.
Pomeranz, A., Z. Korzets, Abraham R. Eliakim, et al.. (1997). Relapsing Henoch-Sch&ouml;nlein Purpura Associated with a Tubo-Ovarian Abscess due to <i>Morganella morganii</i>. American Journal of Nephrology. 17(5). 471–473. 16 indexed citations
19.
Lossos, Alexander, Yaron River, Abraham R. Eliakim, & Israel Steiner. (1995). Neurologic Aspects of Inflammatory Bowel Disease. Neurology. 45(3). 416–421. 180 indexed citations
20.
Stalnikowicz, Ruth, Daniel Feldman Pollak, Abraham R. Eliakim, et al.. (1988). Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal disorders.. Gut. 29(11). 1578–1582. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026